Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study

Teriparatide is the first anabolic agent for osteoporosis, and this analysis aimed to understand responses to teriparatide in Chinese patients with established osteoporosis in subgroups. In this Phase III study of teriparatide in China, 362 patients were randomized at a 2:1 ratio to receive subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Chunyan, Chen, Yun, Zhang, Bin, Chen, Yu, Bai, Fan, Chen, Decai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644555/
https://www.ncbi.nlm.nih.gov/pubmed/29066877
http://dx.doi.org/10.2147/CIA.S140900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644555/
https://www.ncbi.nlm.nih.gov/pubmed/29066877
http://dx.doi.org/10.2147/CIA.S140900

Ejemplares similares